UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Olin Co. (NYSE:OLN - Free Report) by 11.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 297,425 shares of the specialty chemicals company's stock after acquiring an additional 29,919 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.26% of Olin worth $10,053,000 at the end of the most recent quarter.
Several other large investors have also recently made changes to their positions in OLN. Thrivent Financial for Lutherans grew its position in shares of Olin by 5,746.2% in the 4th quarter. Thrivent Financial for Lutherans now owns 1,613,796 shares of the specialty chemicals company's stock worth $54,546,000 after buying an additional 1,586,192 shares during the last quarter. Norges Bank acquired a new stake in shares of Olin in the 4th quarter worth $47,887,000. Fuller & Thaler Asset Management Inc. grew its stake in Olin by 11.5% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 4,543,844 shares of the specialty chemicals company's stock worth $153,582,000 after buying an additional 467,680 shares during the last quarter. Two Sigma Investments LP grew its stake in Olin by 890.4% during the 4th quarter. Two Sigma Investments LP now owns 451,020 shares of the specialty chemicals company's stock worth $15,244,000 after buying an additional 405,480 shares during the last quarter. Finally, Marshall Wace LLP increased its position in Olin by 1,960.7% during the 4th quarter. Marshall Wace LLP now owns 344,962 shares of the specialty chemicals company's stock valued at $11,660,000 after buying an additional 328,222 shares in the last quarter. 88.67% of the stock is owned by institutional investors.
Olin Price Performance
NYSE OLN traded up $1.04 during trading hours on Tuesday, reaching $20.21. The company's stock had a trading volume of 1,048,660 shares, compared to its average volume of 1,635,524. The firm has a market capitalization of $2.33 billion, a price-to-earnings ratio of 22.46 and a beta of 1.56. The company's 50-day moving average is $21.12 and its two-hundred day moving average is $28.18. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.27 and a quick ratio of 0.77. Olin Co. has a 1-year low of $17.66 and a 1-year high of $54.05.
Olin (NYSE:OLN - Get Free Report) last announced its earnings results on Thursday, May 1st. The specialty chemicals company reported $0.04 earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.14. Olin had a return on equity of 5.10% and a net margin of 1.66%. The business had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same period in the prior year, the company posted $0.40 EPS. The business's quarterly revenue was up 1.2% on a year-over-year basis. On average, equities analysts predict that Olin Co. will post 1.38 EPS for the current year.
Olin Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Thursday, May 15th will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 3.96%. The ex-dividend date of this dividend is Thursday, May 15th. Olin's payout ratio is 156.86%.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on OLN. JPMorgan Chase & Co. dropped their price target on Olin from $28.00 to $20.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 6th. Morgan Stanley cut their price target on shares of Olin from $28.00 to $20.00 and set an "underweight" rating on the stock in a research note on Monday, May 12th. KeyCorp lowered their price objective on shares of Olin from $40.00 to $34.00 and set an "overweight" rating for the company in a research note on Monday, April 14th. The Goldman Sachs Group cut their target price on Olin from $33.00 to $25.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 6th. Finally, BMO Capital Markets lowered their price target on Olin from $44.00 to $34.00 and set a "market perform" rating for the company in a research report on Wednesday, February 5th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $27.80.
Check Out Our Latest Analysis on Olin
Olin Company Profile
(
Free Report)
Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.
Read More

Before you consider Olin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Olin wasn't on the list.
While Olin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.